These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22177646)

  • 1. Relation between treatment efficacy and cumulative dose of 3% topical minoxidil in male pattern baldness.
    Choi JW; Na SY; Park KC; Youn SW; Huh CH
    J Am Acad Dermatol; 2012 Jan; 66(1):e10-2. PubMed ID: 22177646
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical minoxidil dose-response effect in alopecia areata.
    Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
    Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male pattern baldness.
    Hogan DJ; Chamberlain M
    South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
    Olsen EA; Weiner MS
    J Am Acad Dermatol; 1987 Jul; 17(1):97-101. PubMed ID: 3301926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
    Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
    Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
    Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
    J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
    Hoedemaker C; van Egmond S; Sinclair R
    Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia in congenital hidrotic ectodermal dysplasia responding to treatment with a combination of topical minoxidil and tretinoin.
    Melkote S; Dhurat RS; Palav A; Jerajani HR
    Int J Dermatol; 2009 Feb; 48(2):184-5. PubMed ID: 19200200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study].
    Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S
    G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical minoxidil in the treatment of alopecia areata and male-pattern alopecia.
    Shi YP
    Arch Dermatol; 1986 May; 122(5):506. PubMed ID: 3707163
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical minoxidil therapy for hereditary male pattern alopecia.
    Roenigk HH; Pepper E; Kuruvilla S
    Cutis; 1987 Apr; 39(4):337-42. PubMed ID: 3556042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical minoxidil: review of efficacy and safety.
    Katz HI
    Cutis; 1989 Jan; 43(1):94-8. PubMed ID: 2644080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of 2% topical minoxidil in the management of male pattern baldness in Chinese.
    Kuan YZ; Chen SY; Chen MJ; Wang CN; Chan HL
    Changgeng Yi Xue Za Zhi; 1990 Jun; 13(2):96-103. PubMed ID: 2224611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical minoxidil for male pattern baldness.
    O'Loughlin S
    Ir Med J; 1991 Mar; 84(1):3-4. PubMed ID: 2045268
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
    Koperski JA; Orenberg EK; Wilkinson DI
    Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
    Tanglertsampan C
    J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of oral minoxidil in the treatment of alopecia areata.
    Fiedler-Weiss VC; Rumsfield J; Buys CM; West DP; Wendrow A
    Arch Dermatol; 1987 Nov; 123(11):1488-90. PubMed ID: 3674909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.